Free Account Opening + AMC Free Demat
Loading...

Avanse Financial Services IPO vs Suraksha Diagnostic IPO

Comparision between Avanse Financial Services IPO and Suraksha Diagnostic IPO.

IPO Details

Avanse Financial Services IPO is a Mainline Book Built Issue IPO proposed to list at BSE, NSE while Suraksha Diagnostic IPO is a Mainline Book Built Issue proposed to list at BSE, NSE.

Issue Size and Price

The total issue size of Avanse Financial Services IPO is up to ₹3,500.00 Cr whereas the issue size of the Suraksha Diagnostic IPO is up to ₹846.25 Cr. The final issue price of Avanse Financial Services IPO is and of Suraksha Diagnostic IPO is .

  Avanse Financial Services IPO Suraksha Diagnostic IPO
Face Value ₹5 per share ₹2 per share
Issue Price (Lower) ₹420.00 per share
Issue Price (Upper) ₹441.00 per share
Issue Price (Final)
Discount (Retail)
Discount (Employee)
Market Lot Size 34 shares
Fresh Issue Size
Fresh Issue Size (Amount) up to ₹1,000.00 Cr
OFS Issue Size 1,91,89,330 shares
OFS Issue Size (Amount) up to ₹2,500.00 Cr up to ₹846.25 Cr
Issue Size Total 1,91,89,330 shares
Issue Size Total (Amount) up to ₹3,500.00 Cr up to ₹846.25 Cr

IPO Timetable

Avanse Financial Services IPO opens on , while Suraksha Diagnostic IPO opens on Nov 29, 2024. The closing date of Avanse Financial Services IPO and Suraksha Diagnostic IPO is , and Dec 03, 2024, respectively.

  Avanse Financial Services IPO Suraksha Diagnostic IPO
Anchor Bid Date Nov 28, 2024
Issue Open Nov 29, 2024
Issue Close Dec 03, 2024
Basis Of Allotment (Tentative) Dec 04, 2024
Initiation of Refunds (Tentative) Dec 05, 2024
Credit of Share (Tentative) Dec 05, 2024
Listing date (Tentative) Dec 06, 2024
Anchor Lockin End date 1 Jan 03, 2025
Anchor Lockin End date 2 Mar 04, 2025

Financials

Avanse Financial Services IPO P/E ratio is , as compared to Suraksha Diagnostic IPO P/E ratio of 99.31.

  Avanse Financial Services IPO Suraksha Diagnostic IPO
Financial

Avanse Financial Services Limited Financial Information (Restated Consolidated)

Avanse Financial Services Limited's revenue increased by 75% and profit after tax (PAT) rose by 117% between the financial year ending with March 31, 2024 and March 31, 2023.

Period Ended31 Mar 202431 Mar 2023
Assets14,343.849,729.95
Revenue1,728.81990.23
Profit After Tax342.4157.71
Net Worth3,676.722,149.72
Reserves and Surplus3,560.382,040.73
Total Borrowing10,135.257,210.13
Amount in ₹ Crore

Suraksha Diagnostic Limited Financial Information (Restated Consolidated)

Suraksha Diagnostic Limited's revenue increased by 14.75% and profit after tax (PAT) rose by 281.32% between the financial year ending with March 31, 2024 and March 31, 2023.

Period Ended30 Jun 202431 Mar 202431 Mar 202331 Mar 2022
Assets314.20300.21281.20275.96
Revenue61.85222.26193.69225.77
Profit After Tax7.6723.136.0720.82
Net Worth187.05179.41155.93145.84
Reserves and Surplus176.80170.88147.40137.31
Total Borrowing7.578.6414.0119.03
Amount in ₹ Crore
Promoter Shareholding (Pre-Issue) 58.38% 61.07%
Promoter Shareholding (Post-Issue)
P/E Ratio 99.31
Market Cap
ROE 14.09%%
ROCE 21.46%%
Debt/Equity 0.2
EPS ₹4.44
RoNW 14.09%%

Shares Offered

In the Avanse Financial Services IPO retail investors (RII) are offered while in Suraksha Diagnostic IPO retail investors are offered . Qualified institutional buyers (QIB) are offered in Avanse Financial Services IPO and in Suraksha Diagnostic IPO.

  Avanse Financial Services IPO Suraksha Diagnostic IPO
Anchor Investor Reserveration
Market Maker Reserveration
QIB
NII
RII
Employee
Others
Total

Bids Received (Subscription)

Avanse Financial Services IPO subscribed in total, whereas Suraksha Diagnostic IPO subscribed .

  Avanse Financial Services IPO Suraksha Diagnostic IPO
QIB (times)
NII (times)
Big NII (times)
Small NII (times)
RII (times)
Employee (times)
Other (times)
Total (times)

Comments

Add a public comment...